Notes from the Field: Seroprevalence Estimates of SARS-CoV-2 Infection in Convenience Sample - Oregon, May 11-June 15, 2020.
作者信息
Sutton Melissa, Cieslak Paul, Linder Meghan
机构信息
Public Health Division, Oregon Health Authority.
出版信息
MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1100-1101. doi: 10.15585/mmwr.mm6932a4.
Abstract
摘要
相似文献
1
Notes from the Field: Seroprevalence Estimates of SARS-CoV-2 Infection in Convenience Sample - Oregon, May 11-June 15, 2020.实地记录：2020年5月11日至6月15日俄勒冈州便利样本中SARS-CoV-2感染的血清阳性率估计
MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1100-1101. doi: 10.15585/mmwr.mm6932a4.
2
Seroprevalence of SARS-Cov-2 in 646 professionals at the Rothschild Foundation Hospital (ProSeCoV study).罗斯柴尔德基金会医院646名专业人员中SARS-CoV-2的血清阳性率（ProSeCoV研究）。
Anaesth Crit Care Pain Med. 2020 Oct;39(5):595-596. doi: 10.1016/j.accpm.2020.08.003. Epub 2020 Aug 27.
3
Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.美国消防部门消防员/护理人员中 SARS-CoV-2 抗体的流行病学：一项横断面研究。
Occup Environ Med. 2020 Dec;77(12):857-861. doi: 10.1136/oemed-2020-106676. Epub 2020 Aug 6.
4
Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands.血清新型冠状病毒特异性抗体阳性率，法罗群岛。
Emerg Infect Dis. 2020 Nov;26(11):2761-2763. doi: 10.3201/eid2611.202736. Epub 2020 Jul 29.
5
Reopening Society and the Need for Real-Time Assessment of COVID-19 at the Community Level.重新开放社会与社区层面新冠病毒病实时评估的必要性
JAMA. 2020 Jun 9;323(22):2247-2248. doi: 10.1001/jama.2020.7872.
6
[Sensitivity, specificity, predictive values in serological Covid-19 tests].[新冠病毒病血清学检测中的敏感性、特异性及预测值]
Epidemiol Prev. 2020 Mar-Jun;44(2-3):189-190. doi: 10.19191/EP20.2-3.P189.042.
7
[SARS-CoV-2, a new causal agent of Guillain-Barre syndrome].[严重急性呼吸综合征冠状病毒2型，吉兰-巴雷综合征的一种新致病原]
Rev Neurol. 2020 Oct 1;71(7):275-276. doi: 10.33588/rn.7107.2020264.
8
Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays.全自动 SARS-CoV-2 IgM 和 IgG 免疫分析的开发和多中心性能评估。
Clin Chem Lab Med. 2020 Jul 15;58(9):1601-1607. doi: 10.1515/cclm-2020-0548. Print 2020 Aug 27.
9
Interpreting Diagnostic Tests for SARS-CoV-2.解读新型冠状病毒2019（SARS-CoV-2）诊断检测结果
JAMA. 2020 Jun 9;323(22):2249-2251. doi: 10.1001/jama.2020.8259.
10
Frequency of COVID-19 IgG Antibodies among Special Police Squad Lahore, Pakistan.巴基斯坦拉合尔特别警察部队中新冠病毒免疫球蛋白G抗体的检测频率
J Coll Physicians Surg Pak. 2020 Jul;30(7):735-739. doi: 10.29271/jcpsp.2020.07.735.
引用本文的文献
1
Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020-June 30, 2022.美国俄勒冈州 2020 年 11 月 1 日至 2022 年 6 月 30 日期间儿科人群 SARS-CoV-2 血清流行率。
Emerg Infect Dis. 2023 Aug;29(8):1672-1675. doi: 10.3201/eid2908.230471.
2
Seroprevalence and SARS-CoV-2 invasion in general populations: A scoping review over the first year of the pandemic.血清流行率和 SARS-CoV-2 在普通人群中的入侵：大流行第一年的范围综述。
PLoS One. 2023 Apr 19;18(4):e0269104. doi: 10.1371/journal.pone.0269104. eCollection 2023.
3
Geographically skewed recruitment and COVID-19 seroprevalence estimates: a cross-sectional serosurveillance study and mathematical modelling analysis.地理分布不均的招募和 COVID-19 血清流行率估计：一项横断面血清学监测研究和数学建模分析。
BMJ Open. 2023 Mar 7;13(3):e061840. doi: 10.1136/bmjopen-2022-061840.
4
Leveraging CTSA hubs for rapid, large-scale, high-impact research: A case study during a global public health emergency.利用临床与转化科学奖（CTSA）中心开展快速、大规模、高影响力研究：全球突发公共卫生事件期间的案例研究
J Clin Transl Sci. 2022 Oct 18;7(1):e13. doi: 10.1017/cts.2022.484. eCollection 2023.
5
The Longitudinal Analysis on the Anti-SARS-CoV-2 Antibodies among Healthcare Workers in Poland-Before and after BNT126b2 mRNA COVID-19 Vaccination.波兰医护人员接种BNT126b2 mRNA新冠疫苗前后抗SARS-CoV-2抗体的纵向分析
Vaccines (Basel). 2022 Sep 20;10(10):1576. doi: 10.3390/vaccines10101576.
6
Missing science: A scoping study of COVID-19 epidemiological data in the United States.缺失的科学：美国 COVID-19 流行病学数据的范围研究。
PLoS One. 2022 Oct 12;17(10):e0248793. doi: 10.1371/journal.pone.0248793. eCollection 2022.
7
Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland.用于苏格兰流行病学监测的严重急性呼吸综合征冠状病毒2血清学检测方法比较
J Clin Virol Plus. 2021 Sep;1(3):100028. doi: 10.1016/j.jcvp.2021.100028. Epub 2021 Jun 14.
8
Reliably quantifying the evolving worldwide dynamic state of the COVID-19 outbreak from death records, clinical parametrization, and demographic data.从死亡记录、临床参数和人口数据可靠地量化 COVID-19 疫情在全球范围内的动态演变。
Sci Rep. 2021 Oct 7;11(1):19952. doi: 10.1038/s41598-021-99273-1.
9
Probability-Based Estimates of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Detection Fraction, Utah, USA.基于概率的美国犹他州严重急性呼吸综合征冠状病毒 2 血清流行率和检出率的估计。
Emerg Infect Dis. 2021 Nov;27(11):2786-2794. doi: 10.3201/eid2711.204435. Epub 2021 Sep 1.
10
Risk of infection and transmission of SARS-CoV-2 among children and adolescents in households, communities and educational settings: A systematic review and meta-analysis.家庭、社区和教育环境中儿童和青少年感染和传播 SARS-CoV-2 的风险：系统评价和荟萃分析。
J Glob Health. 2021 Jul 17;11:05013. doi: 10.7189/jogh.11.05013. eCollection 2021.
本文引用的文献
1
Estimated Community Seroprevalence of SARS-CoV-2 Antibodies - Two Georgia Counties, April 28-May 3, 2020.估计的社区 SARS-CoV-2 抗体血清流行率-佐治亚州两个县，2020 年 4 月 28 日-5 月 3 日。
MMWR Morb Mortal Wkly Rep. 2020 Jul 24;69(29):965-970. doi: 10.15585/mmwr.mm6929e2.
2
Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample - Indiana, April 25-29, 2020.基于全州随机样本的 SARS-CoV-2 感染人群现患率——印第安纳州，2020 年 4 月 25 日-29 日。
MMWR Morb Mortal Wkly Rep. 2020 Jul 24;69(29):960-964. doi: 10.15585/mmwr.mm6929e1.
3
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.2020年3月23日至5月12日美国10个地点针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体的血清流行率
JAMA Intern Med. 2020 Jul 21. doi: 10.1001/jamainternmed.2020.4130.
4
Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho.雅培Architect SARS-CoV-2 IgG检测法的性能特征及爱达荷州博伊西市的血清阳性率
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00941-20.
Zotero 插件